These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1705301)
1. High molecular weight components are main constituents of Mallory bodies isolated with a fluorescence activated cell sorter. Zatloukal K; Böck G; Rainer I; Denk H; Weber K Lab Invest; 1991 Feb; 64(2):200-6. PubMed ID: 1705301 [TBL] [Abstract][Full Text] [Related]
2. High molecular weight component of Mallory bodies detected by a monoclonal antibody. Zatloukal K; Denk H; Spurej G; Lackinger E; Preisegger KH; Franke WW Lab Invest; 1990 Apr; 62(4):427-34. PubMed ID: 1692099 [TBL] [Abstract][Full Text] [Related]
3. Ultrastructural, biochemical, and immunologic characterization of Mallory bodies in livers of griseofulvin-treated mice. Fimbriated rods of filaments containing prekeratin-like polypeptides. Franke WW; Denk H; Schmid E; Osborn M; Weber K Lab Invest; 1979 Feb; 40(2):207-20. PubMed ID: 219290 [TBL] [Abstract][Full Text] [Related]
4. Modifications in cytokeratin and actin in cultured liver cells derived from griseofulvin-fed mice. Cadrin M; Anderson NM; Aasheim LH; Kawahara H; Franks DJ; French SW Lab Invest; 1995 Apr; 72(4):453-60. PubMed ID: 7536860 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of Mallory body, intermediate filament, and microfilament proteins in liver cell primary cultures. An electron microscopic autoradiography assay. Kachi K; Cadrin M; French SW Lab Invest; 1993 Jan; 68(1):71-81. PubMed ID: 7678660 [TBL] [Abstract][Full Text] [Related]
6. A study on Mallory bodies. Isolation, ultrastructure and preliminary biochemical characterization of Mallory bodies from livers of alcoholic cirrhosis and malignant hepatoma. Okamura K Acta Pathol Jpn; 1976 Nov; 26(6):649-70. PubMed ID: 189565 [TBL] [Abstract][Full Text] [Related]
7. Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes. Ohta M; Marceau N; Perry G; Manetto V; Gambetti P; Autilio-Gambetti L; Metuzals J; Kawahara H; Cadrin M; French SW Lab Invest; 1988 Dec; 59(6):848-56. PubMed ID: 2462130 [TBL] [Abstract][Full Text] [Related]
8. Disturbance of keratin homeostasis in griseofulvin-intoxicated mouse liver. Hutter H; Zatloukal K; Winter G; Stumptner C; Denk H Lab Invest; 1993 Nov; 69(5):576-82. PubMed ID: 7504119 [TBL] [Abstract][Full Text] [Related]
9. Mallory bodies: isolation of hepatocellular hyalin and electrophoretic resolution of polypeptide components. Tinberg HM; Regan RJ; Geier EA; Peterson GE; French SW Lab Invest; 1978 Nov; 39(5):483-90. PubMed ID: 83449 [TBL] [Abstract][Full Text] [Related]
10. Isolation and electrophoretic study on Mallory bodies from the livers of alcoholic cirrhosis. Okamura K; Harwood TR; Yokoo H Lab Invest; 1975 Aug; 33(2):193-9. PubMed ID: 51133 [TBL] [Abstract][Full Text] [Related]
11. Mallory body induction in drug-primed mouse liver. Yuan QX; Marceau N; French BA; Fu P; French SW Hepatology; 1996 Sep; 24(3):603-12. PubMed ID: 8781332 [TBL] [Abstract][Full Text] [Related]
12. Comparative electrophoretic study of Mallory body and intermediate filament protein. Sim JS; Franks KE; French SW J Med; 1978; 9(3):211-21. PubMed ID: 283168 [TBL] [Abstract][Full Text] [Related]
13. Mallory body filaments become insoluble after normal assembly into intermediate filaments. Pollanen MS; Markiewicz P; Weyer L; Goh MC; Bergeron C Am J Pathol; 1994 Nov; 145(5):1140-7. PubMed ID: 7526693 [TBL] [Abstract][Full Text] [Related]
14. Mallory body (cytokeratin aggresomes) formation is prevented in vitro by p38 inhibitor. Nan L; Dedes J; French BA; Bardag-Gorce F; Li J; Wu Y; French SW Exp Mol Pathol; 2006 Jun; 80(3):228-40. PubMed ID: 16563375 [TBL] [Abstract][Full Text] [Related]
15. Rearrangement of the hepatocyte cytoskeleton after toxic damage: involution, dispersal and peripheral accumulation of Mallory body material after drug withdrawal. Denk H; Franke WW Eur J Cell Biol; 1981 Feb; 23(2):241-9. PubMed ID: 7193580 [TBL] [Abstract][Full Text] [Related]
16. Change of cytokeratin organization during development of Mallory bodies as revealed by a monoclonal antibody. Hazan R; Denk H; Franke WW; Lackinger E; Schiller DL Lab Invest; 1986 May; 54(5):543-53. PubMed ID: 2422438 [TBL] [Abstract][Full Text] [Related]
17. Experimental Mallory body formation is accompanied by modulation of the expression of multidrug-resistance genes and their products. Preisegger KH; Stumptner C; Riegelnegg D; Brown PC; Silverman JA; Thorgeirsson SS; Denk H Hepatology; 1996 Jul; 24(1):248-52. PubMed ID: 8707270 [TBL] [Abstract][Full Text] [Related]
18. Changes of cytokeratin filament organization in human and murine Mallory body-containing livers as revealed by a panel of monoclonal antibodies. Preisegger KH; Zatloukal K; Spurej G; Denk H Liver; 1991 Oct; 11(5):300-9. PubMed ID: 1720496 [TBL] [Abstract][Full Text] [Related]
19. Use of a specific monoclonal antibody to detect Mallory bodies in liver disease. Leevy CB; Sameshima Y; Yoshioka K; Leevy CM; Kanagasundaram N; Unoura M J Assoc Acad Minor Phys; 1990; 1(2):24-5, 28-30. PubMed ID: 2135694 [TBL] [Abstract][Full Text] [Related]
20. The Mallory body as an aggresome: in vitro studies. Riley NE; Li J; Worrall S; Rothnagel JA; Swagell C; van Leeuwen FW; French SW Exp Mol Pathol; 2002 Feb; 72(1):17-23. PubMed ID: 11784119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]